Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region

Navamedic ASA: Q3 2022 financial results

Navamedic ASA: Invitation to 2022 third quarter presentation

Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation

Navamedic ASA: Q2 and first half 2022 financial results

Navamedic ASA: Invitation to 2022 second quarter presentation